Vimarsana
Biggest News Aggregation in the World

Belapectin Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Belapectin Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Belapectin Program Today - Breaking & Trending Today

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update - Vimarsana News

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

Published: March 29, 2024

29.03.2024 - NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) - Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended ...

Source: wallstreet-online.de
Related Topics:
Richard UihleinChris CalabreseJack CallicuttKhurram JamilKevin GardnerBenjamins CarsonPol BoudesCompany Annual Report On FormBelapectin ProgramDrug AdministrationCompany ContactExchange CommissionGalectin Therapeutics IncChief Medical OfficerFast Track DesignationData SafetyMonitoring BoardLiver MeetingAmerican AssociationLiver DiseasesAnnual ReportFast TrackPrivate Securities Litigation Reform ActChief FinancialRelations Contacts
Galectin Therapeutics : Reports 2023 Financial Results and Provides Business Update - Form 8-K -March 29, 2024 at 07:59 am EDT - Vimarsana News

Galectin Therapeutics : Reports 2023 Financial Results and Provides Business Update - Form 8-K -March 29, 2024 at 07:59 am EDT

Published: March 29, 2024

Galectin Therapeutics, Inc. , the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31,...

Source: marketscreener.com
Related Topics:
Khurram JamilChris CalabreseBenjamins CarsonJack CallicuttJoel LewisPol BoudesRichard UihleinKevin GardnerCompany Annual Report On FormExchange CommissionCompany ContactBelapectin ProgramDrug AdministrationGalectin Therapeutics IncGalectin Therapeutics ReportsProvides Business UpdateChief Executive OfficerGalectin TherapeuticsMetabolic Dysfunction Associated SteatohepatitisSafety Monitoring BoardChief Medical OfficerFast Track DesignationProgram HighlightsData SafetyMonitoring Board